Nanophoria
ItalyEntry
2025
Hold
1yr
Status
Active
Who owns Nanophoria?
Nanophoria is an Italian Biotech company, currently owned by Panakes Partners SGR since 2025 and 2 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
XGen Venture SGRXGEN Venture Life Sciences Fund · 2022 · Life Sciences VC
3 ownership periods · full history below
Key facts
HQItaly
SectorBiotech
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2022 · present
Sofinnova PartnersActive
2022 · present(4yr) · Sofinnova Capital X · 2021 · Life Sciences VC
XGen Venture SGRActive
2025 · present(1yr) · XGEN Venture Life Sciences Fund · 2022 · Life Sciences VC
Panakes Partners SGRActive
2025 · present(1yr) · Panakes Fund Purple · 2021 · Life Sciences VC
More from XGEN Venture Life Sciences Fund
Other portfolio companies in the same fund.
UK
Sweden
SwitzerlandMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Nanophoria?
Nanophoria is currently owned by Panakes Partners SGR, XGen Venture SGR and 1 other, through XGEN Venture Life Sciences Fund, since 2025.
When did Panakes Partners SGR and 2 others acquire Nanophoria?
Panakes Partners SGR and 2 others acquired Nanophoria in 2025.
Who has owned Nanophoria over time?
Nanophoria has been through 3 private-equity ownership periods: Sofinnova Partners · via Sofinnova Capital X · since 2022; Panakes Partners SGR · via Panakes Fund Purple · since 2025; XGen Venture SGR · via XGEN Venture Life Sciences Fund · since 2025.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue